The announcement that Johnson & Johnson’s single-shot vaccine proved 66% effective against the disease and 85% effective against severe COVID-19 illness has added another dose of hope in the global fight against the coronavirus. Dr. Dan Barouch, the Boston researcher who partnered with Johnson & Johnson to lead that vaccine's development, joined Jim Braude to talk about when he expects it to hit the market and the most promising aspects of the findings.
